Hepatic Dose Adjustment Guide
Enter five clinical parameters to calculate a Child-Pugh score, classify hepatic impairment severity, and review general dose adjustment guidance.
Child-Pugh Parameters
Select the value that best matches the patient's clinical status.
Disclaimer: For educational reference only. Always verify against official prescribing information and consult a licensed clinician before adjusting doses.
Child-Pugh Score
—
—
/ 15
—
Select parameters and click Calculate
5 pts — Class A
10 pts — Class C
15 pts
General Dose Adjustment Guidance
Results will appear here after calculation.
Common Hepatically-Cleared Drugs
General patterns only — always check the full prescribing information.
| Drug | Class A | Class B | Class C |
|---|---|---|---|
| Acetaminophen | Normal dose; limit duration | Reduce dose; max 2 g/day | Avoid if possible |
| Atorvastatin | Normal dose | Use with caution; monitor LFTs | Contraindicated |
| Metoprolol | Normal dose | Reduce; start at 25% of normal | Reduce; 12.5%–25% of normal |
| Warfarin | Normal; close INR monitoring | Reduce dose; frequent INR checks | Avoid or use very low doses with intensive monitoring |
| Morphine | Normal; monitor closely | Reduce 25–50%; longer intervals | Reduce 50%+; risk of encephalopathy |
| Diazepam | Normal; monitor sedation | Reduce dose significantly | Avoid; precipitates encephalopathy |
| Propranolol | Normal dose | Reduce by 50%; monitor | Reduce substantially; careful titration |
| Rifampicin | Use with caution | Reduce to 50% of normal dose | Avoid |
Summary
Enter five clinical parameters to calculate a Child-Pugh score, classify hepatic impairment severity, and review general dose adjustment guidance.
How it works
- Enter the five Child-Pugh parameters: bilirubin, albumin, PT prolongation, ascites, and encephalopathy.
- Each parameter scores 1–3 points based on clinical thresholds.
- Total points (5–15) map to Class A (5–6), Class B (7–9), or Class C (10–15).
- The tool displays the class and general dose adjustment guidance for each severity level.
- Review the drug-specific notes table for common hepatically-cleared medications.
Use cases
- Estimate safe starting doses for patients with known liver disease.
- Classify hepatic impairment severity before prescribing hepatically-metabolized drugs.
- Support clinical pharmacy reviews for patients with cirrhosis.
- Educate students and trainees on Child-Pugh scoring methodology.
- Cross-reference with drug labeling guidance for Child-Pugh Class B or C patients.
Frequently Asked Questions
Last updated: 2026-07-23 ·
Reviewed by Nham Vu